Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,821 | 42,459 | 36,754 | 44,092 | 15,340 |
| Depreciation Amortization | 4,184 | 16,511 | 12,442 | 8,335 | 4,183 |
| Income taxes - deferred | 216 | -1,101 | 2,248 | 1,446 | 927 |
| Accounts receivable | 6,083 | 4,564 | 7,933 | -5,918 | 9,424 |
| Accounts payable and accrued liabilities | -10,833 | 1,038 | 4,800 | 5,273 | 1,018 |
| Other Working Capital | -10,321 | 7,592 | 13,924 | 8,710 | 13,202 |
| Other Operating Activity | 38,143 | 11,298 | 2,273 | 4,034 | -8,539 |
| Operating Cash Flow | $-2,349 | $82,361 | $80,374 | $65,972 | $35,555 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,654 | -8,615 | -5,138 | -3,179 | -1,708 |
| Net Acquisitions | -2,000 | -3,750 | -3,750 | N/A | N/A |
| Other Investing Activity | 0 | 1,250 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,654 | $-11,115 | $-8,888 | $-3,179 | $-1,708 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 799 | 2,450 | 2,438 | 735 | 80 |
| Other Financing Activity | -3,323 | -36,753 | -36,269 | -36,205 | -11,167 |
| Financing Cash Flow | $-2,524 | $-34,303 | $-33,831 | $-35,470 | $-11,087 |
| Exchange Rate Effect | 2,172 | -5,261 | -3,939 | -607 | 198 |
| Beginning Cash Position | 81,453 | 49,771 | 49,771 | 49,771 | 49,771 |
| End Cash Position | 74,098 | 81,453 | 83,487 | 76,487 | 72,729 |
| Net Cash Flow | $-7,355 | $31,682 | $33,716 | $26,716 | $22,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,349 | 82,361 | 80,374 | 65,972 | 35,555 |
| Capital Expenditure | -2,654 | -8,615 | -5,138 | -3,179 | -1,708 |
| Free Cash Flow | -5,003 | 73,746 | 75,236 | 62,793 | 33,847 |